Latest News about BAYRY
Recent news which mentions BAYRY
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
November 19, 2024
From Benzinga
Bayer Seeks European Approval For Its Menopause Drug
October 15, 2024
From Benzinga
From Benzinga
Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
September 16, 2024
From Benzinga
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
September 10, 2024
From Benzinga
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
August 30, 2024
From Benzinga
BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024
August 06, 2024
Tickers
BAYRY
From InvestorPlace
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
July 25, 2024
From Benzinga
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
July 08, 2024
From InvestorPlace
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
From InvestorPlace
From Benzinga
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
May 27, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
BAYRY
From InvestorPlace
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
May 10, 2024
From Benzinga
From Benzinga
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
April 10, 2024
From Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
April 09, 2024
From Benzinga
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
April 05, 2024
From Benzinga
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
March 19, 2024
From Benzinga
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
From Benzinga
Tickers
BAYRY
From InvestorPlace
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
March 05, 2024
From Benzinga
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
From InvestorPlace
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
From Benzinga
From InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
